Skip to main content

Guide

Selling prescription medication from an existing brand.

The pharmacy partner model, explained without the hand waving

You already have the audience, the storefront and the customer relationship. What you do not have is the ability to supply a prescription-only medicine, because that requires a registered pharmacy and a prescriber. The route most brands take is to keep the brand and the commerce, and put the clinical and dispensing work with a partner who is registered to do it. This guide covers how that split actually works and where brands get caught out.

None of this is legal advice. Take your own before you trade.

What sits on each side

The line is clearer than people expect once you draw it.

  • Yours: the brand, the marketing, the storefront, the pricing, the customer service tone, the product range you want to offer.
  • The pharmacy's: the clinical decision, the prescription, the dispense, the responsible pharmacist arrangements, the registration.
  • Shared, and contractual: who holds the patient data and on what basis, who answers a complaint, who handles an adverse event, and what happens if either side walks away.

A brand cannot promise a customer a medicine. It can offer an assessment, and the outcome of that assessment is a clinician's call, including no.

Marketing is where brands get into trouble

Prescription-only medicines cannot be advertised to the public in the UK. That rules out naming the drug in ads, in social posts and often on the product page itself. What you can talk about is the condition, the service, the consultation and the outcome. Practically, that means a category page about weight management rather than a product page for a named injectable, and copy reviewed by someone who knows the rules before it ships. Building the funnel around the assessment rather than the molecule also happens to convert better, because the patient is being sold a decision, not a box.

The customer journey that works

  1. The customer arrives on your site, in your brand, and starts an assessment.
  2. The assessment is a real clinical questionnaire, with logic that stops or escalates the risky answers.
  3. Identity is verified, and photos or extra evidence are requested where the product needs them.
  4. Payment happens through your existing checkout, and the submission binds to the customer record.
  5. A prescriber reviews, asks for more information, approves or declines, and signs.
  6. The pharmacy dispenses, labels and ships, and tracking flows back into the order.
  7. Follow-ups, dose changes and cancellations run against the same record, not a spreadsheet.

The whole of that can be white labelled, so the patient sees your brand from the first question to the parcel.

Questions to ask a pharmacy partner

  • Which products can you supply, and which will you refuse?
  • What is your turnaround from approved prescription to dispatch, and what happens at volume?
  • Who are the prescribers, and how is their capacity covered at weekends and peaks?
  • What is the process when a patient fails identity verification or a clinical check?
  • Who owns the patient record, and what do we each get on exit?
  • Is there a backup partner if you cannot fulfil a surge?

The due diligence the regulator now expects

This is no longer a matter of taste. The GPhC expects a pharmacy owner to actively verify that any third-party prescribing service it works with is registered with the right regulator for the specific activity being delivered: the CQC in England, Healthcare Improvement Scotland, RQIA in Northern Ireland, Healthcare Inspectorate Wales, or the GPhC itself. Its position on the rest is blunt: pharmacies should not work with online providers who avoid or try to avoid appropriate UK regulation.

Read that from the brand side and it is a warning as much as a rule. If your prescribing partner cannot show you a current registration covering the exact service, a serious pharmacy will eventually decline to dispense for you, and the arrangement collapses with your customers in the middle of it. Ask for the registration number, check it on the regulator's own register rather than a PDF, and record when you last checked.

If the prescribers are outside the UK

Some brand and partner models route consultations to clinicians abroad, usually on cost or capacity grounds. The guidance flags overseas prescribing arrangements as carrying significant extra risks, and sets out what has to be verified before you rely on one: that the prescriber is registered with their own regulator, that they follow UK prescribing guidelines rather than the norms of where they sit, and that they hold indemnity insurance that actually responds to a UK patient. Add to that the practical question of who a patient, a pharmacist or an investigator reaches when something goes wrong at eleven at night. If you cannot answer all four, the arrangement is a liability wearing a margin.

Where Sync-RX fits

Sync-RX is the layer between your storefront and the pharmacy: the assessment flows, the risk checks, the prescriber workspace and signing, the dispensing documents, the order and subscription management, and the audit trail that both sides need. It is white labelled to your brand, plugs into an existing Shopify or custom checkout, and does not require you to become a pharmacy.

See how to start an online pharmacy in the UK if you are considering registering yourself, or talk to us about the partner route.

Sources and registers

Repeats and cancellation

Ongoing supply is where most services come unstuck. See repeat supply, reassessment and cancellation for the reassessment gate, the record each cycle needs, and how to handle failed payments and cancellations.

Back to guides

Book a Demo